SlideShare uma empresa Scribd logo
1 de 17
[object Object],[object Object],[object Object],STRICTLY CONFIDENTIAL
STRICTLY CONFIDENTIAL This presentation has been issued in connection with a proposed placing (the “Placing”) of new ordinary shares in AntNano plc   (the “Company”).  The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. The information in this presentation is subject to updating, completion, revision, further verification and amendment without notice.  No assurance is given by the Company that any ordinary shares of the Company will be sold in the Placing.  This presentation does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any shares in the Company, nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, or act as an inducement to enter into any contract or commitment therefore. No reliance may be placed for any purpose whatsoever on the information or opinions contained in this presentation or any other document or oral statement, or on the completeness, accuracy or fairness of such information and/or opinions therein. No representation or warranty, express or implied, is made or given by or on behalf of the Company, any of their respective directors, or any other person as to the accuracy or completeness or fairness of the information or opinions contained in this presentation and no responsibility or liability is accepted by any of them for such information or opinions or for any errors, omissions, misstatements, negligent or otherwise, or for any communication written or otherwise, contained or referred to in this presentation. DISCLAIMER
STRICTLY CONFIDENTIAL Accordingly, neither the Company nor any of their respective directors, officers, employees, advisers, associated persons or subsidiary undertakings shall be liable for any direct, indirect or consequential loss or damage suffered by any person as a result of relying upon the statement or as a result of any admission in, or any document supplied with, this presentation or by any future communications in connection with such documents and any such liabilities are expressly disclaimed. Prospective investors interested in investing in the Company are recommended to seek their own independent financial advice from a person authorised for the purposes of the Financial Services and Markets Act 2000. This presentation and its contents are confidential and should not be distributed, published or reproduced in whole or in part or disclosed by recipients to any other person. This presentation is not for distribution outside the United Kingdom and, in particular, should not be distributed to persons with addresses in Canada, Australia, Japan, Republic of Ireland, Republic of South Africa, or to persons with addresses in the United States of America, its territories or possession or to any  citizen thereof or to any corporation, partnership or other entity created or organized under the laws thereof. Any such distribution could result in the violation of  Canadian, Australian, Japanese, Irish, South African or United States of America law. The information in this presentation is confidential and must not be copied, reproduced or distributed to others at any time except for the purposes of analysis by certain employees and advisers of the recipient who have agreed to be bound by the restrictions contained herein.   DISCLAIMER (cont.)
STRICTLY CONFIDENTIAL ,[object Object],[object Object],[object Object],[object Object],Market Pull; Not Tech Push
STRICTLY CONFIDENTIAL The Economic Argument Time Hrs Amortised Cost/test  £ Existing Galley Sampler >150 64 New AntNano Dip Strips 4 30 AntNano Real Time Analyser 0.1 1.5
Real Time Air Analyser ,[object Object],[object Object],[object Object],[object Object],[object Object],STRICTLY CONFIDENTIAL Cyclone Bioreactor Fluorimeter Fluid In Air In Air Out Waste
STRICTLY CONFIDENTIAL High Volume Air Sampling Real Time Measurement Monitoring of Airborne Enzymes Current Product Range
STRICTLY CONFIDENTIAL Route to Market   ,[object Object],[object Object],[object Object],[object Object]
STRICTLY CONFIDENTIAL Customers   ,[object Object],[object Object],[object Object],[object Object],[object Object],Industrial  (Enzyme  Detection) Oestrogen Steroid Detection   Dioxin  Detection Infectious  Disease  Detection   Counter  Terrorism ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
STRICTLY CONFIDENTIAL Sustainable Advantages ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Security Applications
ANT Explosive Approach
[object Object],[object Object],[object Object],[object Object],[object Object],STRICTLY CONFIDENTIAL Management
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],STRICTLY CONFIDENTIAL Management
STRICTLY CONFIDENTIAL Financial Summary
STRICTLY CONFIDENTIAL Summary ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
STRICTLY CONFIDENTIAL ,[object Object],[object Object],[object Object],[object Object],[object Object],Investment Opportunity

Mais conteúdo relacionado

Semelhante a Ant Nano presentation to CONNECT North East Conference 09

Sienna corporate presentation 29 may2017
Sienna corporate presentation 29 may2017Sienna corporate presentation 29 may2017
Sienna corporate presentation 29 may2017
Reach Markets
 
ANGLE plc 30 January 2014: Interim Results for the year ended 31 October 2013
ANGLE plc 30 January 2014: Interim Results for the year ended 31 October 2013ANGLE plc 30 January 2014: Interim Results for the year ended 31 October 2013
ANGLE plc 30 January 2014: Interim Results for the year ended 31 October 2013
ANGLE plc
 
ANGLE Peliminary Results 2013 31jul13
ANGLE Peliminary Results 2013 31jul13ANGLE Peliminary Results 2013 31jul13
ANGLE Peliminary Results 2013 31jul13
ANGLE plc
 

Semelhante a Ant Nano presentation to CONNECT North East Conference 09 (20)

ieCrowd Pesentation
ieCrowd PesentationieCrowd Pesentation
ieCrowd Pesentation
 
Sienna corporate presentation 29 may2017
Sienna corporate presentation 29 may2017Sienna corporate presentation 29 may2017
Sienna corporate presentation 29 may2017
 
ANGLE plc 30 January 2014: Interim Results for the year ended 31 October 2013
ANGLE plc 30 January 2014: Interim Results for the year ended 31 October 2013ANGLE plc 30 January 2014: Interim Results for the year ended 31 October 2013
ANGLE plc 30 January 2014: Interim Results for the year ended 31 October 2013
 
ANGLE Peliminary Results 2013 31jul13
ANGLE Peliminary Results 2013 31jul13ANGLE Peliminary Results 2013 31jul13
ANGLE Peliminary Results 2013 31jul13
 
TLSA Investor Presentation August 2021
TLSA Investor Presentation August 2021TLSA Investor Presentation August 2021
TLSA Investor Presentation August 2021
 
Imugene Limited - ASX: IMU
Imugene Limited - ASX: IMUImugene Limited - ASX: IMU
Imugene Limited - ASX: IMU
 
Imugene Corporate Presentation
Imugene Corporate PresentationImugene Corporate Presentation
Imugene Corporate Presentation
 
Liquid Biopsy 29 January 2015
Liquid Biopsy 29 January 2015Liquid Biopsy 29 January 2015
Liquid Biopsy 29 January 2015
 
TLSA Investor Presentation October 2021
TLSA Investor Presentation October 2021TLSA Investor Presentation October 2021
TLSA Investor Presentation October 2021
 
Liquid biopsy from a simple blood test enabling personalised cancer care | Sh...
Liquid biopsy from a simple blood test enabling personalised cancer care | Sh...Liquid biopsy from a simple blood test enabling personalised cancer care | Sh...
Liquid biopsy from a simple blood test enabling personalised cancer care | Sh...
 
ANGLE Presentation 4 February 2014 Shares Cenkos Investor Forum
ANGLE Presentation 4 February 2014 Shares Cenkos Investor Forum ANGLE Presentation 4 February 2014 Shares Cenkos Investor Forum
ANGLE Presentation 4 February 2014 Shares Cenkos Investor Forum
 
ANGLE shares investor evening 15 April 2015
ANGLE shares investor evening 15 April 2015ANGLE shares investor evening 15 April 2015
ANGLE shares investor evening 15 April 2015
 
Presentation 2 July 2015: Proactive Investors Forum
Presentation 2 July 2015: Proactive Investors Forum  Presentation 2 July 2015: Proactive Investors Forum
Presentation 2 July 2015: Proactive Investors Forum
 
Tiziana Life Sciences (NASDAQ: TLSA) Investor Presentation
Tiziana Life Sciences (NASDAQ: TLSA) Investor PresentationTiziana Life Sciences (NASDAQ: TLSA) Investor Presentation
Tiziana Life Sciences (NASDAQ: TLSA) Investor Presentation
 
Tiziana Life Sciences (NASDAQ: TLSA) Investor Presentation - July 20th 2020
Tiziana Life Sciences (NASDAQ: TLSA) Investor Presentation - July 20th 2020Tiziana Life Sciences (NASDAQ: TLSA) Investor Presentation - July 20th 2020
Tiziana Life Sciences (NASDAQ: TLSA) Investor Presentation - July 20th 2020
 
Cell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval SolutionsCell & Gene Therapy Post-Approval Solutions
Cell & Gene Therapy Post-Approval Solutions
 
Johnson & Johnson Pharmaceutical Business Review
Johnson & Johnson Pharmaceutical Business ReviewJohnson & Johnson Pharmaceutical Business Review
Johnson & Johnson Pharmaceutical Business Review
 
Quintain Consulting Presentation
Quintain Consulting PresentationQuintain Consulting Presentation
Quintain Consulting Presentation
 
AzCI presents: FDA Drug Development 101
AzCI presents: FDA Drug Development 101AzCI presents: FDA Drug Development 101
AzCI presents: FDA Drug Development 101
 
Parsortix non-invasive cancer diagnostics | 3 September 2014
Parsortix non-invasive cancer diagnostics | 3 September 2014Parsortix non-invasive cancer diagnostics | 3 September 2014
Parsortix non-invasive cancer diagnostics | 3 September 2014
 

Último

The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
daisycvs
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
vineshkumarsajnani12
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
ZurliaSoop
 

Último (20)

GUWAHATI 💋 Call Girl 9827461493 Call Girls in Escort service book now
GUWAHATI 💋 Call Girl 9827461493 Call Girls in  Escort service book nowGUWAHATI 💋 Call Girl 9827461493 Call Girls in  Escort service book now
GUWAHATI 💋 Call Girl 9827461493 Call Girls in Escort service book now
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
 
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGBerhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
 
HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024
 
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
 
Organizational Transformation Lead with Culture
Organizational Transformation Lead with CultureOrganizational Transformation Lead with Culture
Organizational Transformation Lead with Culture
 
Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
 
Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...
Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...
Chennai Call Gril 80022//12248 Only For Sex And High Profile Best Gril Sex Av...
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
 
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in PakistanChallenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
Challenges and Opportunities: A Qualitative Study on Tax Compliance in Pakistan
 
Buy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail AccountsBuy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail Accounts
 
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR ESCORTS
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR  ESCORTSJAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR  ESCORTS
JAJPUR CALL GIRL ❤ 82729*64427❤ CALL GIRLS IN JAJPUR ESCORTS
 
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGBerhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Berhampur 70918*19311 CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
 
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAIGetting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
Phases of Negotiation .pptx
 Phases of Negotiation .pptx Phases of Negotiation .pptx
Phases of Negotiation .pptx
 

Ant Nano presentation to CONNECT North East Conference 09

  • 1.
  • 2. STRICTLY CONFIDENTIAL This presentation has been issued in connection with a proposed placing (the “Placing”) of new ordinary shares in AntNano plc (the “Company”). The content of this promotion has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. The information in this presentation is subject to updating, completion, revision, further verification and amendment without notice. No assurance is given by the Company that any ordinary shares of the Company will be sold in the Placing. This presentation does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any shares in the Company, nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, or act as an inducement to enter into any contract or commitment therefore. No reliance may be placed for any purpose whatsoever on the information or opinions contained in this presentation or any other document or oral statement, or on the completeness, accuracy or fairness of such information and/or opinions therein. No representation or warranty, express or implied, is made or given by or on behalf of the Company, any of their respective directors, or any other person as to the accuracy or completeness or fairness of the information or opinions contained in this presentation and no responsibility or liability is accepted by any of them for such information or opinions or for any errors, omissions, misstatements, negligent or otherwise, or for any communication written or otherwise, contained or referred to in this presentation. DISCLAIMER
  • 3. STRICTLY CONFIDENTIAL Accordingly, neither the Company nor any of their respective directors, officers, employees, advisers, associated persons or subsidiary undertakings shall be liable for any direct, indirect or consequential loss or damage suffered by any person as a result of relying upon the statement or as a result of any admission in, or any document supplied with, this presentation or by any future communications in connection with such documents and any such liabilities are expressly disclaimed. Prospective investors interested in investing in the Company are recommended to seek their own independent financial advice from a person authorised for the purposes of the Financial Services and Markets Act 2000. This presentation and its contents are confidential and should not be distributed, published or reproduced in whole or in part or disclosed by recipients to any other person. This presentation is not for distribution outside the United Kingdom and, in particular, should not be distributed to persons with addresses in Canada, Australia, Japan, Republic of Ireland, Republic of South Africa, or to persons with addresses in the United States of America, its territories or possession or to any citizen thereof or to any corporation, partnership or other entity created or organized under the laws thereof. Any such distribution could result in the violation of Canadian, Australian, Japanese, Irish, South African or United States of America law. The information in this presentation is confidential and must not be copied, reproduced or distributed to others at any time except for the purposes of analysis by certain employees and advisers of the recipient who have agreed to be bound by the restrictions contained herein. DISCLAIMER (cont.)
  • 4.
  • 5. STRICTLY CONFIDENTIAL The Economic Argument Time Hrs Amortised Cost/test £ Existing Galley Sampler >150 64 New AntNano Dip Strips 4 30 AntNano Real Time Analyser 0.1 1.5
  • 6.
  • 7. STRICTLY CONFIDENTIAL High Volume Air Sampling Real Time Measurement Monitoring of Airborne Enzymes Current Product Range
  • 8.
  • 9.
  • 10.
  • 11.
  • 13.
  • 14.
  • 16.
  • 17.